IP Verse

Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters - EP3036320

The patent EP3036320 was granted to Biogen MA on Apr 3, 2024. The application was originally filed on Aug 19, 2014 under application number EP14761736A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3036320

BIOGEN MA
Application Number
EP14761736A
Filing Date
Aug 19, 2014
Status
Patent Maintained As Amended
Mar 1, 2024
Publication Date
Apr 3, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ABG LAWJan 28, 2022-ADMISSIBLE

Patent Citations (42) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003070185
DESCRIPTIONUS2005037000
DESCRIPTIONUS2005079574
DESCRIPTIONUS4560655
DESCRIPTIONUS4657866
DESCRIPTIONUS4683195
DESCRIPTIONUS4767704
DESCRIPTIONUS4927762
DESCRIPTIONUS5122469
DESCRIPTIONUS5223409
DESCRIPTIONUS5225539
DESCRIPTIONUS5500362
DESCRIPTIONUS5585089
DESCRIPTIONUS5624821
DESCRIPTIONUS5648260
DESCRIPTIONUS5658727
DESCRIPTIONUS5667988
DESCRIPTIONUS5693761
DESCRIPTIONUS5693762
DESCRIPTIONUS5821337
DESCRIPTIONUS5859205
DESCRIPTIONUS5869046
DESCRIPTIONUS5885793
DESCRIPTIONUS6194551
DESCRIPTIONUS6407213
DESCRIPTIONUS7785880
DESCRIPTIONWO8700195
DESCRIPTIONWO8705330
DESCRIPTIONWO9002809
DESCRIPTIONWO9003430
DESCRIPTIONWO9117271
DESCRIPTIONWO9201047
DESCRIPTIONWO9209690
DESCRIPTIONWO9215679
DESCRIPTIONWO9218619
DESCRIPTIONWO9220791
DESCRIPTIONWO9301288
DESCRIPTIONWO9633735
DESCRIPTIONWO9634096
DESCRIPTIONWO9951642
INTERNATIONAL-SEARCH-REPORTUS2012276631
INTERNATIONAL-SEARCH-REPORTWO9961650

Non-Patent Literature (NPL) Citations (23) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- AN ZHANG ET AL, "Identifying the differences in mechanisms of mycophenolic acid controlling fucose content of glycoproteins expressed in different CHO cell lines : Differences in Mechanisms of Mycophenolic Acid", BIOTECHNOLOGY AND BIOENGINEERING, US, (20161111), vol. 113, no. 11, doi:10.1002/bit.25995, ISSN 0006-3592, pages 2367 - 2376, XP055390256
OPPOSITION- HOSSLER P et al., "Optimal and consistent OD6 protein glycosylation in mammalian cell culture", Glycobiology, (20090603), vol. 19, no. 9, doi:10.1093/glycob/cwp079, pages 936 - 949
OPPOSITION- HOSSLER, P. et al., "Protein Glycosylation Control in Mammalian Cell Culture: Past Precedents and OD3 Contemporary Prospects", Advances in Biochemical, (20111020), vol. 127, doi:10.1007/10_2011_113, pages 187 - 219
OPPOSITION- Laurent Anne F, "Mycophenolic acid suppresses protein N-linked OD9 glycosylation in human monocytes and their 1.01.1996 adhesion to endothelial cells and to some substrates", Experimental Hematology, (19960101), vol. 24, pages 59 - 67
OPPOSITION- Laurent Anne F, "Mycophenolic acid suppresses protein N-linked OD9 glycosylation in human monocytes and their 1.01.1996 adhesion to endothelial cells and to some substrates", Experimental Hematology, (19960101), vol. 24, pages 59 - 67, XP055888710
OPPOSITION- MUNRO, "What can yeast tell us about N-linked OD2 glycosylation in the Golgi apparatus?", FEBS Lett., (20010516), vol. 498, doi:10.1016/S0014-5793(01)02488-7, pages 223 - 227
OPPOSITION- OKELEY et al., "Development of orally active inhibitors of protein and cellular fucosylation", Proc. Natl.Acad.Sci. USA, (20130314), vol. 110, doi:10.1073/pnas.1222263110, pages 5404 - 5409
OPPOSITION- Pamela Stanley Et Al.,, "Chapter 8 - N-Glycans", Essentials of Glycobiology, Second Edition, New York , Cold Spring Harbor Laboratory Press , (20090101), pages 2pp, 101 - 115
OPPOSITION- Pamela Stanley Et Al.,, "Chapter 8 - N-Glycans", Essentials of Glycobiology, Second Edition, New York , Cold Spring Harbor Laboratory Press , (20090101), pages 2pp, 101 - 115, XP055616273
OPPOSITION- SHINKAWA et al., "The absence of fucose but not the presence of OD5 galactose or bisecting N-acetylglucosamine of 8.11.2002 human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity", J. Biol. Chem., (20030131), vol. 278, no. 5, doi:10.1074/jbc.M210665200, pages 3466 - 73
OPPOSITION- Sokoloski John A, Et Al, "Alterations in Glycoprotein Synthesis and Guanosine Triphosphate Levels Associated with the Differentiation of HL-60 Leukemia Cells Produced by Inhibitors of Inosine 5'-Phosphate Dehydrogenase1", CANCER RESEARCH, (19860101), vol. 46, pages 2314 - 2319
OPPOSITION- Sokoloski John A, Et Al, "Alterations in Glycoprotein Synthesis and Guanosine Triphosphate Levels Associated with the Differentiation of HL-60 Leukemia Cells Produced by Inhibitors of Inosine 5'-Phosphate Dehydrogenase1", CANCER RESEARCH, (19860101), vol. 46, pages 2314 - 2319, XP055888717
OPPOSITION- Sokoloski John A, Et Al, "Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism", Molecular Pharmacology, (19851201), vol. 28, no. 6, pages 567 - 573
OPPOSITION- Sokoloski John A, Et Al, "Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism", Molecular Pharmacology, (19851201), vol. 28, no. 6, pages 567 - 573, XP055888697
OPPOSITION- T. Shantha Raju, "Glycosylation Variations with Expression Systems and Their Impact on Biological Activity of Therapeutic Immunoglobulins", BIOPROCESS INTERNATIONAL, INFORMA LIFE SCIENCES GROUP, US, US , ISSN 1542-6319, pages 44 - 53, BIOPROCESS INTERNATIONAL, URL: http://www.qa-bio.com/docs/T.Raju_Glycosylation_Variation_in_Expression_Systems.pdf, (20110330), XP002630661
OPPOSITION- WILDT et al., "The humanization of N- OD1 glycosylation pathways in yeast", Nature Review, (20050200), vol. 3, doi:10.1038/nrmicro1087, pages 119 - 128
OPPOSITION- HOSSLER, P. et al., "Protein Glycosylation Control in Mammalian Cell Culture: Past Precedents and OD3 Contemporary Prospects", Advances in Biochemical, (20111020), vol. 127, doi:10.1007/10_2011_113, pages 187 - 219, XP055679442
OPPOSITION- MUNRO, "What can yeast tell us about N-linked OD2 glycosylation in the Golgi apparatus?", FEBS Lett., (20010516), vol. 498, doi:10.1016/S0014-5793(01)02488-7, pages 223 - 227, XP004597910
OPPOSITION- WILDT et al., "The humanization of N- OD1 glycosylation pathways in yeast", Nature Review, (20050200), vol. 3, doi:10.1038/nrmicro1087, pages 119 - 128, XP009064525
OPPOSITION- OKELEY et al., "Development of orally active inhibitors of protein and cellular fucosylation", Proc. Natl.Acad.Sci. USA, (20130314), vol. 110, doi:10.1073/pnas.1222263110, pages 5404 - 5409, XP055115464
OPPOSITION- SHINKAWA et al., "The absence of fucose but not the presence of OD5 galactose or bisecting N-acetylglucosamine of 8.11.2002 human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity", J. Biol. Chem., (20030131), vol. 278, no. 5, doi:10.1074/jbc.M210665200, pages 3466 - 73, XP002965857
OPPOSITION- HOSSLER P et al., "Optimal and consistent OD6 protein glycosylation in mammalian cell culture", Glycobiology, (20090603), vol. 19, no. 9, doi:10.1093/glycob/cwp079, pages 936 - 949, XP055112498
OPPOSITION- BERTALANFFY P et al., "Alterations of endothelial nucleotide levels by OD11 mycophenolic acid result in changes of membrane 01.03.1999 glycosylation and E-selectin expression.", Clin. Chem. Lab. Med., (19990000), vol. 37, no. 3, doi:10.1515/CCLM.1999.045, pages 259 - 264, XP055145115

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents